XML 50 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Operating Activities        
Net income / (loss) $ (278,000)      
BIOMED REALTY, L.P.
       
Interest Paid, Capitalized     9,614,000 6,015,000
Operating Activities        
Net income / (loss) 39,865,000 32,497,000    
Adjustments to reconcile net income to net cash provided by operating activities        
Depreciation and amortization 125,145,000 124,320,000    
Allowance for doubtful accounts 532,000 708,000    
Non-cash revenue adjustments 564,000 9,313,000    
Other non-cash adjustments 5,376,000 9,864,000    
Compensation expense related to restricted common stock and LTIP units / share-based payments 7,479,000 6,079,000    
Distributions representing a return on capital from unconsolidated partnerships 264,000 119,000    
Change in operating assets and liabilities        
Accounts receivable (1,458,000) (1,438,000)    
Accrued straight-line rents (8,267,000) (11,458,000)    
Deferred leasing costs (6,551,000) (12,321,000)    
Other assets (17,085,000) 1,047,000    
Accounts payable, accrued expenses and other liabilities 4,507,000 (14,155,000)    
Net cash provided by operating activities 150,371,000 144,575,000    
Investing activities        
Purchases of investments in real estate and related intangible assets (135,036,000) (471,910,000)    
Capital expenditures (179,689,000) (75,936,000)    
Contributions from historic tax credit transactions, net of deferred costs 22,557,000 8,620,000    
Contributions From New Market Tax Credit Transaction Net Of Deferred Costs   4,078,000    
Draws on construction loan receivable (39,769,000) (70,947,000)    
Proceeds from Collection of Loans Receivable 184,239,000      
Contributions to unconsolidated partnerships, net (1,257,000) (999,000)    
Purchases of debt and equity securities (9,221,000) (7,309,000)    
Proceeds from the sale of debt and equity securities 13,952,000 73,000    
Net cash used in investing activities (144,224,000) (614,330,000)    
Financing activities        
Proceeds from issuance of OP units   641,236,000    
Redemption of Series A preferred stock   (198,000,000)    
Payments of Debt Issuance Costs 3,086,000 486,000    
Unsecured line of credit proceeds 658,000,000 541,000,000    
Unsecured line of credit payments (631,000,000) (419,000,000)    
Proceeds from Sale and Collection of Mortgage Notes Receivable 14,043,000      
Principal payments on mortgage notes payable (338,104,000) (4,305,000)    
Proceeds from Issuance of Other Long-term Debt 397,632,000 0    
Dividends paid to common stockholders / unitholders (98,918,000) (77,370,000)    
Dividends paid to preferred stockholders / unitholders   (6,043,000)    
Net cash provided by financing activities (1,433,000) 477,032,000    
Effect of exchange rate changes on cash and cash equivalents (416,000) 413,000    
Net increase / (decrease) in cash and cash equivalents 4,298,000 7,690,000    
Cash and cash equivalents at beginning of period 34,706,000 19,976,000 19,976,000  
Cash and cash equivalents at end of period 39,004,000 27,666,000 34,706,000 19,976,000
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest (net of amounts capitalized of $4,192 and $2,840 during the three months ended March 31, 2014 and 2013, respectively) 45,414,000 45,243,000    
Supplemental disclosure of non-cash investing and financing activities:        
Accrual for common stock dividends / unit distributions declared 49,483,000 46,381,000    
Accrued additions to real estate and related intangible assets 100,424,000 44,693,000    
Debt Instrument, Unamortized Premium       8,671,000
equity issued in connection with Wexford Merger and 320 Charles Street acquisition 0 165,114,000    
Notes Assumed 71,937,000 254,735,000    
equity issued in connection with 100 College Street and 300 George Street acquisition 21,740,000      
Parent Company
       
Interest Paid, Capitalized     9,614,000 6,015,000
Operating Activities        
Net income / (loss) 39,865,000 32,497,000    
Adjustments to reconcile net income to net cash provided by operating activities        
Depreciation and amortization 125,145,000 124,320,000    
Allowance for doubtful accounts 532,000 708,000    
Non-cash revenue adjustments 564,000 9,313,000    
Other non-cash adjustments 5,376,000 9,864,000    
Compensation expense related to restricted common stock and LTIP units / share-based payments 7,479,000 6,079,000    
Distributions representing a return on capital from unconsolidated partnerships 264,000 119,000    
Change in operating assets and liabilities        
Accounts receivable (1,458,000) (1,438,000)    
Accrued straight-line rents (8,267,000) (11,458,000)    
Deferred leasing costs (6,551,000) (12,321,000)    
Other assets (17,085,000) 1,047,000    
Accounts payable, accrued expenses and other liabilities 4,507,000 (14,155,000)    
Net cash provided by operating activities 150,371,000 144,575,000    
Investing activities        
Purchases of investments in real estate and related intangible assets (135,036,000) (471,910,000)    
Capital expenditures (179,689,000) (75,936,000)    
Contributions from historic tax credit transactions, net of deferred costs 22,557,000 8,620,000    
Contributions From New Market Tax Credit Transaction Net Of Deferred Costs   4,078,000    
Draws on construction loan receivable (39,769,000) (70,947,000)    
Proceeds from Collection of Loans Receivable 184,239,000      
Contributions to unconsolidated partnerships, net (1,257,000) (999,000)    
Purchases of debt and equity securities (9,221,000) (7,309,000)    
Proceeds from the sale of debt and equity securities 13,952,000 73,000    
Net cash used in investing activities (144,224,000) (614,330,000)    
Financing activities        
Proceeds from common stock offering   668,552,000    
Payment of offering costs   (27,316,000)    
Redemption of Series A preferred stock   (198,000,000)    
Payments of Debt Issuance Costs 3,086,000 486,000    
Unsecured line of credit proceeds 658,000,000 541,000,000    
Unsecured line of credit payments (631,000,000) (419,000,000)    
Proceeds from Sale and Collection of Mortgage Notes Receivable 14,043,000      
Principal payments on mortgage notes payable (338,104,000) (4,305,000)    
Proceeds from Issuance of Other Long-term Debt 397,632,000      
Distributions to operating partnership unit and LTIP unit holders (2,761,000) (1,375,000)    
Dividends paid to common stockholders / unitholders (96,157,000) (75,995,000)    
Dividends paid to preferred stockholders / unitholders   (6,043,000)    
Net cash provided by financing activities (1,433,000) 477,032,000    
Effect of exchange rate changes on cash and cash equivalents (416,000) 413,000    
Net increase / (decrease) in cash and cash equivalents 4,298,000 7,690,000    
Cash and cash equivalents at beginning of period 34,706,000 19,976,000 19,976,000  
Cash and cash equivalents at end of period 39,004,000 27,666,000 34,706,000 19,976,000
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest (net of amounts capitalized of $4,192 and $2,840 during the three months ended March 31, 2014 and 2013, respectively) 45,414,000 45,243,000    
Supplemental disclosure of non-cash investing and financing activities:        
Accrual for common stock dividends / unit distributions declared 48,132,000 45,108,000    
Accrual for distributions declared for operating partnership unit and LTIP unit holders 1,351,000 1,273,000    
Accrued additions to real estate and related intangible assets 100,424,000 44,693,000    
Debt Instrument, Unamortized Premium       8,671,000
equity issued in connection with Wexford Merger and 320 Charles Street acquisition 0 165,114,000    
Notes Assumed 71,937,000 254,735,000    
equity issued in connection with 100 College Street and 300 George Street acquisition $ 21,740,000